Responses
Regular and young investigator award abstracts
Clinical trials in progress
387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
